Ignite Creation Date:
2025-12-26 @ 11:46 AM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT04082416
Status:
COMPLETED
Last Update Posted:
2023-05-11
First Post:
2019-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Sponsor:
RemeGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-01
First Submit QC Date:
None
Study First Post Date:
2019-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-10
Last Update Post Date:
2023-05-11
Last Update Post Date Type:
ACTUAL